Discontinuation report NOCDURNA
| Report ID | 142013 |
| Drug Identification Number | 02431076 |
| Brand name | NOCDURNA |
| Common or Proper name | Desmopressin Orally Disintegrating Tablet |
| Company Name | FERRING INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | DESMOPRESSIN |
| Strength(s) | 50MCG |
| Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
| Route of administration | SUBLINGUAL SUBLINGUAL |
| Packaging size | Blister of 10, 3 blisters per Carton for package of 30 |
| ATC code | H01BA |
| ATC description | POSTERIOR PITUITARY LOBE HORMONES |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2021-07-31 |
| Actual discontinuation date | 2021-07-31 |
| Remaining supply date | 2021-07-31 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | 50 mcg stock anticipated to depleted by 31-Jul-2021 |
| Company comments | For patients, please discuss alternative treatment options with your health care professional. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 200 YORKLAND BLVD TORONTO, ONTARIO CANADA M2J 5C1 |
| Company contact information | 1-800-263-4057 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2021-11-18 | French | Compare |
| v3 | 2021-11-18 | English | Compare |
| v2 | 2021-07-08 | French | Compare |
| v1 | 2021-07-08 | English | Compare |
Showing 1 to 4 of 4